inclusion criteria: - positive for covid-19 with any approved rt-pcr or rapid antigen test within 7 days of planned treatment - either have no covid-19 symptoms (asymptomatic) or mild symptoms - must be willing and able to comply with all planned study procedures and be available for all study visits and follow-up as required by this protocol - subject must have provided written informed consent which includes signing the institutional review board or independent ethics committee approved consent form prior to participating in any study related activity - willing to follow contraception guidelines

inclusion criteria: - positive for covid-19 with any approved rt-pcr or rapid antigen test within 7 days of planned treatment - either have no covid-19 symptoms (asymptomatic) or mild symptoms - must be willing and able to comply with all planned study procedures and be available for all study visits and follow-up as required by this protocol - subject must have provided written informed consent which includes signing the institutional review board or independent ethics committee approved consent form prior to participating in any study related activity - willing to follow contraception guidelines